Coating Place, a U.S.-based contract development and manufacturing organization (CDMO), has secured a strategic growth investment from 1315 Capital, a Philadelphia-based private equity firm focused on healthcare. 

The investment will enable Coating Place to expand operations to meet growing demand for its services across the pharmaceutical, nutraceutical, animal health, and industrial markets. 

“This investment marks an exciting milestone for Coating Place as we celebrate our 50th anniversary and prepare for the next chapter of growth,” said Tim Breunig, CEO of Coating Place. “We are excited to partner with 1315 Capital. Combined with their industry expertise and strategic growth mindset, we will accelerate growth across the many industries we serve.” 

Coating Place provides microencapsulation solutions using proprietary equipment and processes, supporting customers from product formulation to commercial manufacturing.

“Coating Place has a compelling opportunity to scale its best-in-class platform, offering highly specialized services and deep technical expertise for customers developing complex modified-release products,” said Matthew Reber, partner at 1315 Capital. “We’re proud to partner with Tim and his team as the company expands its commercial reach in order to serve the large and growing need for its services.”